v3.25.2
CONDENSED CONSOLIDATED STATEMENTS OF REDEEMABLE NON-CONTROLLING INTERESTS AND EQUITY - USD ($)
shares in Thousands, $ in Millions
Total
Redeemable Non-Controlling Interests
Common Stock
Additional Paid-In Capital
Accumulated Other Comprehensive Income (Loss)
Accumulated Deficit
Non-Redeemable Non-Controlling Interests
Beginning balance at Dec. 31, 2023   $ 654          
Increase (Decrease) in Temporary Equity [Roll Forward]              
Foreign currency translation adjustment $ (8) (2)     $ (8)    
Recognition of non-controlling interest upon capital investment   19          
Net income (loss)   (20)          
Ending balance at Mar. 31, 2024   651          
Beginning balance (in shares) at Dec. 31, 2023     2,071,144        
Beginning balance at Dec. 31, 2023 12,028   $ 0 $ 42,264 (421) $ (30,594) $ 779
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Exercise of stock options (in shares)     2,421        
Exercise of stock options 18     18      
Stock-based compensation 493     493      
Issuance of common stock for settlement of RSUs (in shares)     13,160        
Shares withheld related to net share settlement (in shares)     (478)        
Shares withheld related to net share settlement (36)     (36)      
Unrealized gain (loss) on investments in available-for-sale debt securities, net of tax (8)       (8)    
Foreign currency translation adjustment (8) (2)     (8)    
Net income (loss) (643)         (654) 11
Other 4     4      
Ending balance (in shares) at Mar. 31, 2024     2,086,247        
Ending balance at Mar. 31, 2024 11,848   $ 0 42,743 (437) (31,248) 790
Beginning balance at Dec. 31, 2023   654          
Increase (Decrease) in Temporary Equity [Roll Forward]              
Foreign currency translation adjustment (49)            
Ending balance at Jun. 30, 2024   631          
Beginning balance (in shares) at Dec. 31, 2023     2,071,144        
Beginning balance at Dec. 31, 2023 12,028   $ 0 42,264 (421) (30,594) 779
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Unrealized gain (loss) on investments in available-for-sale debt securities, net of tax (9)            
Foreign currency translation adjustment (49)            
Ending balance (in shares) at Jun. 30, 2024     2,097,951        
Ending balance at Jun. 30, 2024 13,152   $ 0 43,062 (479) (30,233) 802
Beginning balance at Mar. 31, 2024   651          
Increase (Decrease) in Temporary Equity [Roll Forward]              
Foreign currency translation adjustment (41) (1)     (41)    
Net income (loss)   (19)          
Ending balance at Jun. 30, 2024   631          
Beginning balance (in shares) at Mar. 31, 2024     2,086,247        
Beginning balance at Mar. 31, 2024 11,848   $ 0 42,743 (437) (31,248) 790
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Exercise of stock options (in shares)     2,760        
Exercise of stock options 73     73      
Exercise of restricted stock units (in shares)     469        
Stock-based compensation 470     470      
Issuance of common stock for settlement of RSUs (in shares)     10,488        
Issuance of common stock under the Employee Stock Purchase Plan (in shares)     2,893        
Issuance of common stock under the Employee Stock Purchase Plan 103     103      
Shares withheld related to net share settlement (in shares)     (68)        
Shares withheld related to net share settlement (5)     (5)      
Repurchase of common stock (in shares)     (4,838)        
Repurchase of common stock (326)     (326)      
Unrealized gain (loss) on investments in available-for-sale debt securities, net of tax (1)       (1)    
Foreign currency translation adjustment (41) (1)     (41)    
Net income (loss) 1,027         1,015 12
Other 4     4   0 0
Ending balance (in shares) at Jun. 30, 2024     2,097,951        
Ending balance at Jun. 30, 2024 13,152   $ 0 43,062 (479) (30,233) 802
Beginning balance at Dec. 31, 2024   93          
Increase (Decrease) in Temporary Equity [Roll Forward]              
Re-measurement of non-controlling interest   18          
Foreign currency translation adjustment $ 31       31    
Net income (loss)   (18)          
Ending balance at Mar. 31, 2025   93          
Beginning balance (in shares) at Dec. 31, 2024 2,107,953   2,107,953        
Beginning balance at Dec. 31, 2024 $ 22,383   $ 0 42,801 (517) (20,726) 825
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Exercise of stock options (in shares)     657        
Exercise of stock options 8     8      
Stock-based compensation 448     448      
Issuance of common stock for settlement of RSUs (in shares)     10,293        
Shares withheld related to net share settlement (in shares)     (460)        
Shares withheld related to net share settlement (33)     (33)      
Repurchase of common stock (in shares)     (26,587)        
Repurchase of common stock (1,800)     (1,800)      
Re-measurement of non-controlling interest (18)     (18)      
Unrealized gain (loss) on investments in available-for-sale debt securities, net of tax 1       1    
Foreign currency translation adjustment 31       31    
Net income (loss) 1,792         1,780 12
Ending balance (in shares) at Mar. 31, 2025     2,091,856        
Ending balance at Mar. 31, 2025 22,812   $ 0 41,406 (485) (18,946) 837
Beginning balance at Dec. 31, 2024   93          
Increase (Decrease) in Temporary Equity [Roll Forward]              
Foreign currency translation adjustment $ 83            
Ending balance at Jun. 30, 2025   183          
Beginning balance (in shares) at Dec. 31, 2024 2,107,953   2,107,953        
Beginning balance at Dec. 31, 2024 $ 22,383   $ 0 42,801 (517) (20,726) 825
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Exercise of stock options (in shares) 1,029            
Unrealized gain (loss) on investments in available-for-sale debt securities, net of tax $ (1)            
Foreign currency translation adjustment $ 83            
Ending balance (in shares) at Jun. 30, 2025 2,086,768   2,086,768        
Ending balance at Jun. 30, 2025 $ 23,447   $ 0 40,625 (435) (17,592) 849
Beginning balance at Mar. 31, 2025   93          
Increase (Decrease) in Temporary Equity [Roll Forward]              
Re-measurement of non-controlling interest   14          
Redemption of non-controlling interest   (39)          
Recognition of non-controlling interest upon acquisition   130          
Foreign currency translation adjustment 52 1     52    
Net income (loss)   (16)          
Ending balance at Jun. 30, 2025   183          
Beginning balance (in shares) at Mar. 31, 2025     2,091,856        
Beginning balance at Mar. 31, 2025 22,812   $ 0 41,406 (485) (18,946) 837
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Exercise of stock options (in shares)     370        
Exercise of stock options 7     7      
Stock-based compensation 489     489      
Issuance of common stock for settlement of RSUs (in shares)     8,809        
Issuance of common stock under the Employee Stock Purchase Plan (in shares)     2,151        
Issuance of common stock under the Employee Stock Purchase Plan 119     119      
Shares withheld related to net share settlement (in shares)     (58)        
Shares withheld related to net share settlement (5)     (5)      
Repurchase of common stock (in shares)     (16,360)        
Repurchase of common stock (1,377)     (1,377)      
Re-measurement of non-controlling interest (14)     (14)      
Unrealized gain (loss) on investments in available-for-sale debt securities, net of tax (2)       (2)    
Foreign currency translation adjustment 52 $ 1     52    
Net income (loss) $ 1,366         1,354 12
Ending balance (in shares) at Jun. 30, 2025 2,086,768   2,086,768        
Ending balance at Jun. 30, 2025 $ 23,447   $ 0 $ 40,625 $ (435) $ (17,592) $ 849